uce
ProgressImage ProgressImage
Alkem Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 539523 border-img ISIN Demat INE540L01014 border-img Book Value 984.46 border-img NSE Symbol ALKEM border-img Div & Yield % 0.76 border-img Market Cap ( Cr.) 58167.77 border-img P/E 27.83 border-img EPS 174.78 border-img Face Value 2
Quarters
ParticularsMar 2025
()
Dec 2024
()
Sep 2024
()
Gross Sales2044.942286.832354.72
Other Operating Income0.000.000.00
Other Income 162.65216.07175.92
Total Income2207.592502.902530.64
Total Expenditure 1748.151629.001714.43
PBIDT459.44873.90816.21
Interest 16.9121.0017.18
PBDT442.53852.90799.03
Depreciation91.6467.6161.30
Tax36.75119.88102.38
Fringe Benefit Tax0.000.000.00
Deferred Tax37.20-57.71-62.23
Reported Profit After Tax276.94723.12697.58
Extra-ordinary Items 51.0646.8955.73
Adjusted Profit After Extra-ordinary item225.88676.23641.85
    
EPS (Unit Curr.)18.8960.4858.34
EPS (Adj) (Unit Curr.)18.8960.4858.34
Calculated EPS (Unit Curr.)23.1760.4958.35
Calculated EPS (Adj) (Unit Curr.)23.1760.4958.35
Calculated EPS (Ann.) (Unit Curr.)92.66241.95233.40
Calculated EPS (Adj) (Ann.) (Unit Curr.)92.66241.95233.40
Book Value (Unit Curr.)0.000.000.00
Dividend (%)1850.001850.000.00
Equity23.9123.9123.91
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)22.4738.2134.66
PBDTM(%)21.6437.3033.93
PATM(%)13.5431.6229.62
x
x
×
Let's Chat
close
refresh